Marson D C, Ingram K K, Cody H A, Harrell L E
Department of Neurology, University of Alabama at Birmingham, USA.
Arch Neurol. 1995 Oct;52(10):949-54. doi: 10.1001/archneur.1995.00540340029010.
To assess empirically the competency of patients with Alzheimer's disease (AD) to consent to medical treatment under different legal standards (LSs).
Comparison of normal older subjects and patients with AD on measures of competency to consent to medical treatment.
University medical center.
Normal older control subjects (n = 15) and patients with probable AD (n = 29 [15 with mild and 14 with moderate AD]).
Two specialized clinical vignettes were developed that test a subject's capacity to consent to medical treatment under five well-established LSs for this competency: LS1, evidencing treatment choice; LS2, making the reasonable choice; LS3, appreciating consequences of choice; LS4, providing rational reasons for choice; and LS5, understanding treatment situation and choices. Performance on the LSs was compared across control and AD groups using Student's t test, chi 2, and analysis of variance. Demented subjects were categorized as competent, marginally competent, or incompetent under each LS by using a cutoff score derived from normal control performance.
No differences between groups emerged for LS1 and LS2. Control subjects performed significantly better than patients with mild AD on LS4 and LS5, and significantly better than patients with moderate AD on LS3, LS4, and LS5. Patients with mild AD performed significantly better than patients with moderate AD on LS4 and LS5. With respect to competency status, patients with AD showed a consistent and progressive pattern of compromise (marginal competence or incompetence) related to dementia severity and stringency of the LS.
A reliable prototype instrument validly discriminated the competency performance and classified the competency status of control subjects and patients with mild and moderate AD under five LSs for competency to consent to medical treatment. While the groups performed equivalently on minimal standards requiring merely a treatment choice (LS1) or the reasonable treatment choice (LS2), patients with mild AD had difficulty with more difficult standards requiring rational reasons (LS4) and understanding treatment information (LS5), and patients with moderate AD had difficulty with appreciation of consequences (LS3), rational reasons (LS4), and understanding treatment (LS5). The results raised the concern that many patients with mild AD may not be competent to consent to treatment and supported the value of standardized clinical vignettes for assessment of competency in dementia.
根据不同法律标准(LSs),通过实证评估阿尔茨海默病(AD)患者同意接受医学治疗的能力。
比较正常老年受试者和AD患者在同意接受医学治疗能力方面的指标。
大学医学中心。
正常老年对照受试者(n = 15)和可能患有AD的患者(n = 29 [15例轻度AD和14例中度AD])。
制定了两个专门的临床案例,用于测试受试者在五个既定的同意接受医学治疗能力的法律标准下同意接受医学治疗的能力:标准1(LS1),表明治疗选择;标准2(LS2),做出合理选择;标准3(LS3),认识选择的后果;标准4(LS4),为选择提供合理理由;标准5(LS5),理解治疗情况和选择。使用学生t检验、卡方检验和方差分析比较对照组和AD组在各法律标准下的表现。通过使用从正常对照表现得出的临界值,将痴呆受试者在每个法律标准下分类为有能力、勉强有能力或无能力。
在标准1和标准2方面,两组之间没有差异。在标准4和标准5上,对照受试者的表现明显优于轻度AD患者,在标准3、标准4和标准5上,对照受试者的表现明显优于中度AD患者。在标准4和标准5上,轻度AD患者的表现明显优于中度AD患者。关于能力状态,AD患者表现出与痴呆严重程度和法律标准严格程度相关的一致且渐进的受损模式(勉强有能力或无能力)。
一种可靠的原型工具有效地区分了能力表现,并根据五个同意接受医学治疗能力的法律标准对对照受试者以及轻度和中度AD患者的能力状态进行了分类。虽然两组在仅要求治疗选择(标准1)或合理治疗选择(标准2)的最低标准上表现相当,但轻度AD患者在需要合理理由(标准4)和理解治疗信息(标准5)的更严格标准上存在困难,而中度AD患者在认识后果(标准3)、合理理由(标准4)和理解治疗(标准5)方面存在困难。结果引发了人们对许多轻度AD患者可能无能力同意接受治疗的担忧,并支持了标准化临床案例在评估痴呆患者能力方面的价值。